Login to Your Account



Arbitrator Awards Amgen $150M In Johnson & Johnson Dispute

By Randall Osborne


Tuesday, October 22, 2002
Amgen Inc.'s arbitration against Johnson & Johnson over epoetin alfa ended with a bang - the pharmaceutical company must pay Amgen $150 million - but who (if anyone) should whimper was uncertain, since Amgen had asked for much more. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription